1      0

ISHLTv Recorded Webinars

ISHLTv_05 - Pulmonary Hypertension: Where We're Going We Don't Need Roads


‐ Jul 22, 2020 10:30am

Members: Free

An ISHLT 2020 Oral Session Presentation

Scientific Program Agenda:

Moderator:
Sarah Medrek, MD, University of New Mexico, Albuquerque, NM, USA

Welcome, Session Overview
Oksana Shlobin, MD, Inova Fairfax Hospital, Falls Church, VA, USA
Liaison, ISHLT 2020 Program Committee PH Group

Program Introduction
Moderator

(12) Results from the REPAIR Study: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH)

A. Vonk Noordegraaf1, R. Channick2, E. Cottreel3, D. Kiely4, N. Martin3, O. Moiseeva5, A. Peacock6, A. Tawakol7, A. Torbicki8, S. Rosenkranz*9, N. Galiè* (*co-last authors)10. 1Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands, 2David Geffen School of Medicine at UCLA, Los Angeles, CA, 3Actelion Pharmaceuticals Ltd, Allschwil, Switzerland, 4Royal Hallamshire Hospital, Sheffield, United Kingdom, 5Almazov National Medical Research Centre, St Petersburg, Russian Federation, 6Scottish Pulmonary Vascular Unit, Glasgow, United Kingdom, 7Massachusetts General Hospital and Harvard Medical School, Boston, MA, 8Department of Pulmonary Circulation CMKP at European Health Center, Otwock, Poland, 9Heart Center at the University of Cologne, and Cologne Cardiovascular Research Center (CCRC), Cologne, Germany, 10Department of Experimental, Diagnostic and Specialty Medicine – DIMES, University of Bologna, Bologna, Italy

(14) INSPIRE: Final Results from a Phase 3, Open-Label, Pivotal Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension

N. S. Hill1, J. P. Feldman2, S. Sahay3, D. Levine4, R. F. Roscigno5, T. A. Vaughn5, T. M. Bull6. 1Pulmonary, Tufts Medical Center, Boston, MA, 2Arizona Pulmonary Specialists, Phoenix, AZ, 3Houston Methodist Hospital, Houston, TX, 4University of Texas Health Sciences Center at San Antonio, San Antonio, TX, 5Liquidia Technologies, Morrisville, NC, 6Anschutz Medical Campus, University of Colorado Denver, Aurora, CO

(15) The Relationship between Pulmonary Artery Pulse Pressure and Pulmonary Artery Wedge Pressure during Exercise in Health and in Patients with Suspected Pulmonary Hypertension

R. F. Bentley1, M. Barker1, S. Esfandiari1, S. P. Wright1, F. H. Valle1, J. T. Granton2, S. Mak1. 1Division of Cardiology, Sinai Health System, Toronto, ON, Canada, 2Division of Respirology, University Health Network, Toronto, ON, Canada

(16) Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study

R. L. Benza1, H. W. Farber2, A. E. Frost3, H. A. Ghofrani4, P. A. Corris5, B. Brockmann6, S. Nikkho7, C. Meier8, M. M. Hoeper9. 1Ohio State University, Columbus, OH, 2Pulmonary Hypertension Center, Boston University/Boston Medical Center, Boston, MA, 3Department of Medicine, Houston Methodist, Houston, TX, 4Member of the German Center for Lung Research (DZL), University of Giessen and Marburg Lung Center (UGMLC), Glessen, Germany, 5Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 6CHRESTOS Concept GmbH & Co. KG, Essen, Germany, 7Global Clinical Development, Bayer AG, Berlin, Germany, 8Global Medical Affairs, Bayer AG, Berlin, Germany, 9Clinic for Respiratory Medicine, Hannover Medical School, member of the German Center for Lung Research (DZL), Hannover, Germany

(17) Patients with Methamphetamine-Associated Pulmonary Arterial Hypertension Have Less Favorable Hemodynamics Than Other Patients with Group 1 PAH

E. Vasti1, A. Papolos2, N. A. Kolaitis3, J. Mayfield3, G. H. Tison2, T. De Marco4. 1Department of Medicine, University of California, San Francisco, San Francisco, CA, 2Department of Medicine, Division of Cardiology, University of California, San Francisco, San Francisco, CA, 3Department of Medicine, Division of Pulmonology, University of California, San Francisco, San Francisco, CA, 4Department of Medicine, Division of Cardiology, University of California, San Francisco, University of California, CA

(18) Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension

J. S. Khural1, B. A. Houston1, P. J. Leary2, S. C. Mathai3, T. M. Kolb3, R. Damico3, H. M. Paul3, D. A. Kass4, S. Hsu4, R. J. Tedford1. 1Division of Cardiology, Department of Medicine, The Medical University of South Carolina, Charleston, SC, 2Division of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Washington, Seattle, WA, 3Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, 4Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD

Q & A Segment with all presenters
Led by Moderator


ISHLT Pulmonary Vascular Disease Interdisciplinary Network Update
Ioana Preston, MD, Tufts Medical Center, Boston, MA, USA
Chair, Pulmonary Vascular Disease Interdisciplinary Network Steering Committee

ISHLT Announcements
Greg Schultz, CEO, ISHLT, Addison, TX, USA

Adjourn

Speaker(s):

You must be logged in and own this session in order to post comments.